Robert W Siegel

11PUBLICATIONS
70CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)GlycoconjugatesVertebrate biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Separation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 01, 2026
GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain.

|Feb 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products.

Jennifer K Lee, Ha-Na Lee, Sudhir Agrawal

|Jan 02, 2026
A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia.

Ye Yang, Anne P Beigneux, Troy L Lowe

|Aug 19, 2025
A universal monoallelic human leukocyte antigen class II immunopeptidomic platform for defining the immunogenicity potential of therapeutic proteins.

Megan B Lannan, Wenyu Ming, Laura J Spindler

|Apr 16, 2024
Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.

Yan Q Chen, Ye Yang, Eugene Y Zhen

|Jul 20, 2023
A Monovalent Fab Affinity-Capture and Elution Bridging Immunoassay Overcomes Rheumatoid Factor Interference while Accurately Detecting Antidrug Antibodies.

Boris Calderon, Nichole A Reynolds, Craig A Swearingen

Pageof 2

Frequent Collaborators

5 joint publications

Robert J Konrad

3 joint publications

Michael Ploug

3 joint publications

Yuewei Qian

3 joint publications

Stephen G Young